Muscoloskeletal manifestations in inflammatory bowel disease

Canadian Journal of Gastroenterology

Volumn 15, Issue 6, 2001, Pages 399-403

  Fornaciari, G ^a   Salvarani, C ^a   Beltrami, M ^a   Macchioni, P ^a   Stockbrugger R W ^a   Russel, M G ^a  

^a S MARIA NUOVA HOSPITAL   (Italy)

Author keywords

Extraintestinal manifestation; Inflammatory bowel disease; Spondylarthropathy

Indexed keywords

AZATHIOPRINE; MERCAPTOPURINE; MESALAZINE; NONSTEROID ANTIINFLAMMATORY AGENT; SALAZOSULFAPYRIDINE; STEROID; SULFAPYRIDINE;

ACHILLES TENDON; ARTHRITIS; BUTTOCK; CLINICAL FEATURE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DRUG INDICATION; ENTERITIS; ENTHESITIS; HIP RADIOGRAPHY; HUMAN; INTESTINE MUCOSA; MUSCULOSKELETAL DISEASE; MYALGIA; PATHOGENESIS; PHYSIOTHERAPY; PREVALENCE; PRIORITY JOURNAL; PROCTOCOLECTOMY; REMISSION; REST; REVIEW; SACROILIITIS; SPONDYLOARTHROPATHY; TENDINITIS; THORAX PAIN; ULCERATIVE COLITIS;

EID: 0034926135     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2001/612531     Document Type: Review

References (43)

1. Complications and sequelae of chronic ulcerative colitis
2. The arthritis of ulcerative colitis
3. The European spondylarthropathy study group preliminary criteria for the classification of spondylarthropathy
4. Evaluation of diagnostic criteria for ankylosing spondylitis: A proposal for modification of the New York criteria
5. Inflammatory bowel disease
6. Spondyloarthritis in patients with ulcerative colitis
7. The arthritis of ulcerative colitis: Clinical and genetic aspects
8. Incidence of inflammatory bowel disease across Europe: Is there a difference between North and South? Results of the European Collaborative Study on inflammatory bowel disease (EC-IBD)
9. Seronegative arthritis and the bowel
10. Review article: Bone and joint diseases in inflammatory bowel disease
11. Immune-related systemic manifestations of inflammatory bowel disease: A prospective study of 792 patients
12. Extracolonic diagnoses in ulcerative colitis: An epidemiological study
13. Spondyloarthropathy and idiopathic inflammatory bowel diseases
14. Destructive lesions of small joints in seronegative spondyloarthropathies: Relation to gut inflammation
15. Peripheral arthropathies in inflammatory bowel disease: Their articular distribution and natural history
16. Joint symptoms after restorative proctocolectomy in ulcerative colitis and familial polyposis coli
17. Extraintestinal manifestations of ulcerative colitis following restorative proctocolectomy
18. Comparison of bone scan, computed tomography, and magnetic resonance imaging in the diagnosis of active sacroiliitis
19. Clinical features and prognosis of patients with possible ankylosing spondylitis: Results of a 10-year follow up
20. Symposium of population studies in the rheumatic diseases: New diagnostic criteria
21. Enteropathic spondylarthropathy in chronic inflammatory bowel disease: Prevalence, pattern of manifestations and HLA-association
22. Destructive arthritis of the hip in Crohn's disease
23. Rheumatological complications of GI disorders
24. HLA B27 in regional enteritis with and without ankylosing spondylitis and sacroilitis
25. M-cells are damaged and increased in number in inflamed human ileal mucosa
26. Dual binding capacity of mucosal immunoblasts to mucosal and synovial endothelium in human dissection of the molecular mechanism
27. Distinctive cell activation markers in colon from patients with Crohn's disease and ulcerative colitis
28. Crohn's disease associated with arthritis. A possible role for cross-reactivity between gut bacteria and cartilage in the pathogenesis of arthritis
29. The evolution of spondylarthropathy in relation to gut histology. I. Clinical aspects
30. The evolution of spondylarthropathy in relation to gut histology. II. Histological aspects
31. High frequency of silent inflammatory bowel disease in spondylarthropathy
32. A shared and unique peptide in the human colon, eye and joint detected by monoclonal antibody
33. Arthritis and the gut
34. Extraintestinal considerations in inflammatory bowel disease
35. Colonic ulceration associated with nonsteroidal anti-inflammatory drugs
36. NSAIDs activate quiescent inflammatory bowel disease
37. Analgesic ingestion and other factors preceding relapse in ulcerative colitis
38. Meta-analysis of sulphasalazine in ankylosing spondylitis
39. Sulphasalazine in the treatment of spondylarthropathy: Randomized, multicenter, double-blind, placebo controlled study
40. Which is the active moiety of sulphasalazine in ankylosing spondylitis? A randomized, controlled study
41. Second-line treatment in sero-negative spondylarthropathies
42. Clinical history as a screening test for ankylosing spondylitis